Although insulin therapy has been shown to reduce the risk of neonatal macrosomia and rate of serious perinatal outcomes such us shoulder dystocia or perinatal death (12), the benefits of insulin treatment in pregnancy often do not extend to preventing neonatal hypoglycaemia, frequently requiring intravenous glucose infusion and neonatal high-level nursery admission (13). This evidence concerns the gene INS and Large for gestational age.